Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.

by Jon Kelvey

Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

by Kate Yandell

Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

by Marcus A. Banks

Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

by Ashley P. Taylor

Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.

by Marci A. Landsmann

Before you order an at-home genetic testing kit, carefully consider the medical, psychological and legal implications.

by Tina Segura

A trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation.

by Cheryl Platzman Weinstock

A study suggests women are more likely than men to undergo genetic testing for mutations linked to hereditary cancer.

by Cheryl Platzman Weinstock